Clinical Trials Browser

Phase 2 × Active not recruiting × GRN163L peptide × Clear all

NCT05583552 2025-03-14

IMpress

Phase 2 Active not recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute